Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 47, Issue 3, 2007, Pages 222-225

  Remorgida, Valentino ^a   Abbamonte, Luiza Helena ^a   Ragni, Nicola ^a   Fulcheri, Ezio ^b   Ferrero, Simone ^a,b  

^a Department of Obstetrics and Gynaecology ^*  (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Aromatase inhibitors; Chronic pelvic pain; Deep dyspareunia; Dysmenorrhoea; Endometriosis; Letrozole

Indexed keywords

AROMATASE INHIBITOR; CALCIT VITAMINA D3; CALCIUM; DESOGESTREL; LETROZOLE; ORAL CONTRACEPTIVE AGENT; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; ANALGESIA; ARTICLE; ASTHENIA; BLOATING; BONE DENSITY; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; FEMALE; HUMAN; LAPAROSCOPY; MUSCULOSKELETAL PAIN; NAUSEA; OVARY CYST; PELVIS PAIN SYNDROME; PERIPHERAL EDEMA; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE; VAGINA BLEEDING; WEIGHT GAIN;

ADULT; AROMATASE INHIBITORS; CONTRACEPTIVES, ORAL, SYNTHETIC; DESOGESTREL; DRUG THERAPY, COMBINATION; ENDOMETRIOSIS; FEMALE; HUMANS; NITRILES; OVARIAN CYSTS; PELVIC PAIN; PROSPECTIVE STUDIES; TRIAZOLES;

EID: 34250312453     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2007.00722.x     Document Type: Article

References (13)

1. Ferrero S, Abbamonte LH, Anserini P, Remorgida V, Ragni N. Future perspectives in the medical treatment of endometriosis. Obstet Gynecol Surv 2005; 60: 817-826.
2. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996; 81: 174-179.
3. Takayama K, Zeitoun K, Gunby RT, Sasano H, Carr BR, Bulun SE. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 1998; 69: 709-713.
4. Razzi S, Fava A, Sartini A, De Simone S, Cobellis L, Petraglia F. Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman. BJOG 2004; 111: 182-184.
5. Shippen ER, West WJ Jr. Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor. Fertil Steril 2004; 81: 1395-1398.
6. Ailawadi RK, Jobanputra S, Kataria M, Gurates B, Bulun SE. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: A pilot study. Fertil Steril 2004; 81: 290-296.
7. Amsterdam LL, Gentry W, Jobanputra S, Wolf M, Rubin SD, Bulun SE. Anastrazole and oral contraceptives: A novel treatment for endometriosis. Fertil Steril 2005; 84: 300-304.
8. Hefler LA, Grimm C, van Trotsenburg M, Nagele F. Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: A pilot study. Fertil Steril 2005; 84: 1033-1036.
9. Mitwally MF, Casper RF. Aromatase inhibitors in ovulation induction. Semin Reprod Med 2004; 22: 61-78.
10. American Fertility Society. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril 1985; 43: 351-352.
11. Biscaldi E, Ferrero S, Fulcheri E, Ragni N, Remorgida V, Rollandi GA. Multislice CT enteroclysis in the diagnosis of bowel endometriosis. Eur Radiol 2007; 17: 211-219.
12. Rice CF, Killick SR, Dieben T, Coelingh Bennink H. A comparison of the inhibition of ovulation achieved by desogestrel 75 micrograms and levonorgestrel 30 micrograms daily. Hum Reprod 1999; 14: 982-985.
13. Collins D. Selectivity information on desogestrel. Am J Obstet Gynecol 1993; 168: 1010-1016.